MedTrace Logo

Topiramate for Hospitalized Patients With Alcoholism: a 12-week Study

NCT01135602 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2011-08-15

No results posted yet for this study

Summary

12-week, open-label study of topiramate in hospitalized patients with alcoholism

Conditions

  • Alcohol Dependence

Interventions

DRUG

Topiramate

Topiramate 50-300 mg/day Orally Twice per day

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Principal Investigators

  • Manit Srisurapanont, MD · Department of Psychiatry, Faculty of Medicine, Chiang Mai University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135602 on ClinicalTrials.gov